May 2006
Volume 47, Issue 13
ARVO Annual Meeting Abstract  |   May 2006
Dopamine Regulates Phosducin Ser–73 Phosphorylation in Mouse Retina
Author Affiliations & Notes
  • N. Pozdeyev
    Emory University School of Medicine, Atlanta, GA
  • A. Visser
    Emory University School of Medicine, Atlanta, GA
  • S. Rozov
    Emory University School of Medicine, Atlanta, GA
  • R.H. Lee
    VA Greater LA Healthcare System at Sepulveda, North Hills, and UCLA Jules Stein Eye Institute, Los Angeles, CA
  • P.M. Iuvone
    Emory University School of Medicine, Atlanta, GA
  • Footnotes
    Commercial Relationships  N. Pozdeyev, None; A. Visser, None; S. Rozov, None; R.H. Lee, None; P.M. Iuvone, None.
  • Footnotes
    Support  NIH Grant EY014764
Investigative Ophthalmology & Visual Science May 2006, Vol.47, 3738. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N. Pozdeyev, A. Visser, S. Rozov, R.H. Lee, P.M. Iuvone; Dopamine Regulates Phosducin Ser–73 Phosphorylation in Mouse Retina . Invest. Ophthalmol. Vis. Sci. 2006;47(13):3738.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Phosducin is a 28–kDa phosphoprotein expressed at high levels in photoreceptor cells. Phosducin harbors a consensus phosphorylation site for cAMP–dependent protein kinase (PKA) at Ser–73. Phosducin is phosphorylated and complexed with 14–3–3 proteins in dark adapted photoreceptors. In response to light, phosducin is dephosphorylated, released from the complex with 14–3–3 proteins, and binds to G protein ßγ subunits, which regulate signal transduction within photoreceptors. Photoreceptor cells express dopamine D4 receptors coupled to cAMP metabolism. We hypothesize that dopamine may regulate phosducin function by binding to D4 receptors and inhibiting cAMP dependent Ser–73 phosphorylation by PKA.

Methods: : Experiments were performed on wild type and dopamine D4 receptor knock–out mice on a C57Bl/6J background. Immunoblotting with phosphospecific (pSer–73) and pan–phosducin antibodies was used to quantify pSer–73 and total phosducin. Quinpirole, a dopamine D2/D4 receptor agonist, was injected intraperitoneally at doses 0.01–3 mg/kg of body weight.

Results: : Quinpirole dose–dependently decreased pSer–73 of phosducin in retinas of dark–adapted wild type mice, mimicking the effect of light; quinpirole had no effect on the total phosducin concentration. Quinpirole did not affect phosducin phosphorylation in retinas of D4 knock–out mice. Exposure of dark–adapted wild type animals to 60 min of light caused ∼83% reduction in pSer–73 phosducin. In contrast, light exposure under these conditions decreased pSer–73 phosducin in D4 receptor knock–out mice by only ∼20%. During the daytime, when the retinal dopamine concentration is high, the amount of pSer–73 phosducin was significantly higher in D4 knock–out mice when compared to wild type controls.

Conclusions: : These data indicate that activation of dopamine D4 receptors decreases phosducin Ser–73 phosphorylation in photoreceptor cells. We suggest that the regulation of phosducin function by dopamine may serve as a mechanism regulating diurnal changes in signaling in photoreceptor cells.

Keywords: retina: neurochemistry • dopamine • phosphorylation 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.